Literature DB >> 16427103

Androgen receptor expression in normal, hyperplastic and neoplastic hepatoid glands in the dog.

G Pisani1, F Millanta, D Lorenzi, I Vannozzi, A Poli.   

Abstract

Neoplasms of the perianal glands are common in the dog, particularly in the male. The occurrence of these tumours appears to be hormone related and castration, without excision of the tumour, has sometimes resulted in regression of the tumour. The aim of this study was to investigate the expression of androgen receptors (AR) in normal, hyperplastic and neoplastic hepatoid glands in the dog. Thirty-one samples of canine hepatoid gland tissues were investigated. The lesions, classified according to WHO criteria, were comprised of 19 hyperplastic tissues, 10 benign lesions (2 hepatoid gland epithelioma and 8 hepatoid adenomas), and 19 carcinomas. Five samples from normal hepatoid glands were also investigated. The AR expression was evaluated by immunohistochemistry using a streptavidin-biotin peroxidase method. The immunoexpression was scored by two pathologists as the percentage of positive nuclei. The intensity of staining was also considered. AR expression was detected in all normal and abnormal glands. However, in hyperplastic tissues the percentage of positive nuclei was significantly higher than in normal tissue and especially in reserve basaloid cells. A similar increase in the percent of positive nuclei was also observed in hepatoid epitheliomas, while in hepatoid adenoma the percent of AR-immunolabelling was only slightly increased compared to normal tissue. In hepatoid carcinomas the percent of AR-positive cells was similar to that observed in benign tumours. The grade of differentiation of hepatoid carcinomas did not affect AR expression. These results demonstrate that increased AR expression is maintained throughout perianal gland cancer progression and that hepatoid gland carcinomas still express AR. Although further studies may be required to evaluate the hormonal background of these diseases, dogs bearing those carcinomas might benefit from castration or anti hormonal therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427103     DOI: 10.1016/j.rvsc.2005.11.001

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.

Authors:  Chul Park; Jong-Hyun Yoo; Ha-Jung Kim; Chae-Young Lim; Ju-Won Kim; So-Young Lee; Jung-Hyun Kim; Jae-Im Jang; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-11       Impact factor: 1.008

2.  EGF Level in Hepatoid Gland Adenomas and Hepatoid Gland Epitheliomas in Dogs After Administering Tamoxifen.

Authors:  Aleksandra Sobczyńska-Rak; Beata Żylińska; Łukasz Jarosz; Adam Brodzki; Marcin Tatara
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Epidemiological Investigation of Canine Mammary Tumors in Mainland China Between 2017 and 2021.

Authors:  Hui-Hua Zheng; Chong-Tao Du; Chao Yu; Yu-Zhu Zhang; Rong-Lei Huang; Xin-Yue Tang; Guang-Hong Xie
Journal:  Front Vet Sci       Date:  2022-06-22

4.  Increased p63 Expression in Canine Perianal Gland Tumours.

Authors:  Soo-Hyeon Kim; Byung-Joon Seung; Seung-Hee Cho; Ha-Young Lim; Hee-Myung Park; Jung-Hyang Sur
Journal:  J Vet Res       Date:  2018-10-24       Impact factor: 1.744

5.  Androgen and Estrogen Receptor Expression in Different Types of Perianal Gland Tumors in Male Dogs.

Authors:  Adam Brodzki; Wojciech Łopuszyński; Yolanda Millan; Marcin R Tatara; Piotr Brodzki; Katarzyna Kulpa; Natalia Minakow
Journal:  Animals (Basel)       Date:  2021-03-19       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.